Verrica Pharmaceuticals Inc. (1NE.F)
| Previous close | 6.32 |
| Open | 6.57 |
| Bid | 6.47 x 0 |
| Ask | 6.55 x 0 |
| Day's range | 6.57 - 6.57 |
| 52-week range | 2.60 - 6.60 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 278.488M |
| Beta (5Y monthly) | 1.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.38 |
| Earnings date | 07 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.83 |
ZacksStrength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Simply Wall St.Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss
This week we saw the Verrica Pharmaceuticals Inc. ( NASDAQ:VRCA ) share price climb by 11%. But over the last three...
GlobeNewswireVerrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
WEST CHESTER, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica’s President & Chief Executive Officer, will present at the upcoming 23rd Annual Needham Virtual Healthcare Conference, which is being held virtually from April 8-11, 2024. Event details:Date: Tuesday, April 9, 2024Time: 2:15 pm ET Participa
